Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Dasotraline Pediatric Extension Study

ClinicalTrials.gov ID: NCT02457819

Public ClinicalTrials.gov record NCT02457819. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 21, 2026, 8:17 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

An Open-label, Flexibly-dosed, 26-Week Extension Safety Study of Dasotraline in Children and Adolescents With Attention Deficit Hyperactivity Disorder (ADHD)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This is an open label 26 week extension study for subjects who completed SEP360-202.

Study identification

NCT ID
NCT02457819
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Sumitomo Pharma America, Inc.
Industry
Enrollment
237 participants

Conditions and interventions

Eligibility (public fields only)

Age range
6 Years to 12 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 30, 2015 (Actual)
Primary completion
Feb 2, 2017 (Actual)
Completion
Feb 2, 2017 (Actual)
Last update posted
Jan 28, 2020

2015 – 2017

United States locations

U.S. sites
36
U.S. states
19
U.S. cities
33
Facility City State ZIP Site status
Harmonex Neuroscience Research, Inc Dothan Alabama 36303 —
ProScience Research Group Culver City California 90230 —
Elite Clinical Trials, Inc. Wildomar California 92595 —
MCB Clinical Research Centers, LLC Colorado Springs Colorado 80910 —
Sarkis Clinical Trials Gainesville Florida 32607 —
Indago Research Health Center, Inc. Hialeah Florida 33012 —
Clinical Neuroscience Solutions, Inc Jacksonville Florida 32256 —
Florida Clinical Research Center, LLC Maitland Florida 32751 —
Clinical Neuroscience Solutions, Inc. Orlando Florida 32801 —
Miami Research Associates, LLC South Miami Florida 33143 —
Atlanta Center for Medical Research Atlanta Georgia 30331 —
iResearch Atlanta, LLC Decatur Georgia 30030 —
Capstone Clinical Research Libertyville Illinois 60418 —
Baber Research Group, Inc. Naperville Illinois 630-896-3530 —
Goldpoint Clinical Research, LLC. Indianapolis Indiana 46260 —
Pedia Research,LLC Newburgh Indiana 47630 —
Psychiatric Associates Overland Park Kansas 66211 —
Pedia Research,LLC Owensboro Kentucky 42301 —
Neurobehavioral Medicine Group, Clinical Trials Division Bloomfield Hills Michigan 48302 —
Clinical Trials group at the Rochester Center for Behavioral Medicine Rochester Hills Michigan 48307 —
St. Charles Psychiatric Associates - Midwest Research Group Saint Charles Missouri 63304 —
Center for Psychiatry and Behavioral Medicine, Inc. Las Vegas Nevada 89128 —
Pharmaceutical Research Associates, Inc. Marlton New Jersey 08053 —
Richarmond Behavioral Associates Staten Island New York 10312 —
University of Cincinnati/Department of Psychiatry and Behavioral Neuroscience Cincinnati Ohio 45219 —
University Hospitals Case Medical Center Cleveland Ohio 44106 —
IPS Research Company Oklahoma City Oklahoma 73103 —
Cutting Edge Research Group Oklahoma City Oklahoma 73116 —
Cyn3rgy Research Gresham Oregon 97030 —
Coastal Carolina Research Center Mt. Pleasant South Carolina 29464 —
BioBehavioral Research of Austin P.C. Austin Texas 78759 —
Bayou City Research, Ltd. Houston Texas 77007 —
Houston Clinical Trials, LLC Houston Texas 77098 —
Clinical Trials of Texas, Inc. San Antonio Texas 78229 —
Road Runner Research, Ltd. San Antonio Texas 78258 —
Family Psychiatry of the Woodlands The Woodlands Texas 77381 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02457819, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 28, 2020 · Synced Oct 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT02457819 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →